““
Analyzing the Prevalence of Specific Solid Tumor Types in Randomized Controlled Trials and Their Corresponding Patient-Reported Outcomes
In recent years, healthcare has increasingly focused on patient-reported outcomes (PROs) related to solid tumors. This change marks an important move to integrate patient views into clinical research, especially in randomized controlled trials (RCTs). The prevalence of certain solid tumor types like breast, lung, colorectal, prostate, bladder, and gynecological cancers has attracted attention from medical […]...
04 Nov 2024